Literature DB >> 15657520

Open-configuration MR-guided microwave thermocoagulation therapy for metastatic liver tumors from breast cancer.

Hajime Abe1, Yoshimasa Kurumi, Shigeyuki Naka, Hisanori Shiomi, Tomoko Umeda, Hiroyuki Naitoh, Yoshihiro Endo, Kazuyoshi Hanasawa, Shigehiro Morikawa, Tohru Tani.   

Abstract

BACKGROUND: Liver metastases from breast cancer are associated with a poor prognosis, however, local control with microwave thermocoagulation therapy has been used in certain subgroups of these patients in the past decade. In this study, open-configuration magnetic resonance (MR) -guided microwave thermocoagulation therapy was used for metastatic liver tumors from breast cancer, and the efficacy of this treatment was assessed.
METHODS: Between June 2000 and April 2004, we used MR-guided microwave thermocoagulation therapy on 11 nodules in 8 patients with metastatic liver tumors from breast cancer. The procedure was carried out under general anesthesia. A 0.5 T open-configuration MR system and a microwave coagulator were used. Near-real-time MR images and real-time temperature images were collected and displayed on the monitor. The MR-compatible thoracoscope was used and combined with MR imaging guidance. Navigation software, a 3D Slicer, was installed and customized.
RESULTS: The customized navigation software displayed near-real-time MR images. The percutaneous puncture into the tumors was successful in all cases. No mortality or major complications occurred as a result of the procedures. Five of the 8 patients are alive with new metastatic foci with a mean observation period of 25.9 months.
CONCLUSIONS: We developed several devices to allow safe, easy, and accurate MR-guided microwave thermocoagulation therapy of liver tumors. Open-configuration MR-guided microwave thermocoagulation therapy appears to be a feasible method for tumor ablation of metastatic liver tumors from breast cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657520     DOI: 10.2325/jbcs.12.26

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  8 in total

Review 1.  MR-guided microwave ablation for malignancies.

Authors:  Yoshimasa Kurumi; Tohru Tani; Shigeyuki Naka; Hisanori Shiomi; Tomoharu Shimizu; Hajime Abe; Yoshihiro Endo; Shigehiro Morikawa
Journal:  Int J Clin Oncol       Date:  2007-04-27       Impact factor: 3.402

Review 2.  Thermal ablation therapies in patients with breast cancer liver metastases: a review.

Authors:  Thomas J Vogl; Parviz Farshid; Nagy N N Naguib; Stephan Zangos
Journal:  Eur Radiol       Date:  2012-10-13       Impact factor: 5.315

3.  Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.

Authors:  Maria Franca Meloni; Anita Andreano; Paul F Laeseke; Tito Livraghi; Sandro Sironi; Fred T Lee
Journal:  Radiology       Date:  2009-08-25       Impact factor: 11.105

Review 4.  Interventional navigation systems for treatment of unresectable liver tumor.

Authors:  Soo Jay Phee; Kai Yang
Journal:  Med Biol Eng Comput       Date:  2009-12-30       Impact factor: 2.602

5.  1.0 T open-configuration magnetic resonance-guided microwave ablation of pig livers in real time.

Authors:  Jun Dong; Liang Zhang; Wang Li; Siyue Mao; Yiqi Wang; Deling Wang; Lujun Shen; Annan Dong; Peihong Wu
Journal:  Sci Rep       Date:  2015-08-28       Impact factor: 4.379

Review 6.  Perspectives of breast cancer thermotherapies.

Authors:  Edouard Alphandéry
Journal:  J Cancer       Date:  2014-05-29       Impact factor: 4.207

7.  CalliSpheres drug-eluting beads transarterial-chemoembolization in the treatment of liver metastases from breast cancer: Initial experience in 14 patients.

Authors:  Xu Chang; Peng Sun; Jianxin Zhang; Lin Zhang; Huiyong Wu; Yinfa Xie; Jibing Liu
Journal:  Medicine (Baltimore)       Date:  2021-12-30       Impact factor: 1.889

8.  2450-MHz microwave ablation of liver metastases under 3.0 T wide-bore magnetic resonance guidance: a pilot study.

Authors:  Kaihao Xu; Zhaonan Li; Yiming Liu; Zaoqu Liu; Chaoyan Wang; Dechao Jiao; Xinwei Han
Journal:  Sci Rep       Date:  2022-07-25       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.